While cancers such as breast, lung, and prostate frequently dominate public health discussions, there is a far less recognised but equally aggressive form - sarcoma. It affects thousands across the UK ...

VCU Massey is the first U.S. site in a global phase 2a trial for PTX-100, targeting cutaneous T-cell lymphoma. The BIPAVE-001 trial is evaluating AI-081, a PD-1 and VEGF bispecific antibody, for ...

Data recently presented at the International Association for the Study of Lung Cancer (IASLC) 2024 World Conference on Lung Cancer Treatment with Annamycin results in statistically significant ...

In recent years, cell therapies have developed alongside chemotherapy and immunotherapy to become a new pillar in the treatment of patients with blood and lymph gland cancer. In solid tumors, such as ...

SOME SHOWERS. ALL RIGHT, THANK YOU. ETHAN. WELL, JULIA SARCOMA AWARENESS MONTH AND I’M PLEASED TO BE JOINED BY DOCTOR KURT WEISS. HE’S WITH UPMC AND ORTHOPEDIC SURGEON. AND I UNDERSTAND DOCTOR WEISS, ...

The Chinese biotech is now conducting a Phase III study on glecirasib and sitneprofatib, which could see it gain approval on home soil.

Low screening rates and the stigma of smoking mean many patients are diagnosed too late to benefit from treatments, according ...

Every July, Sarcoma Awareness Month reminds us of a cancer that’s often sidelined in public discourse. However, sarcoma is not just one disease, it is a group of rare cancers with over 150 subtypes, ...

Two complementary studies led by researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), have demonstrated a new RNA-based therapeutic strategy that ...

Scores of supporters filed into WedMake Soccer Park in Cary, North Carolina to participate in the 16th Annual Strike Out for Sarcoma 5K & 10K Run/Walk on Sept. 8. Jordan Farrell (left) and Wanda ...